| Literature DB >> 21772982 |
Arjun Sengupta1, Angika Basant, Soumita Ghosh, Shobhona Sharma, Haripalsingh M Sonawat.
Abstract
(1)H NMR-based metabonomics was used to investigate the multimodal response of mice to malarial parasite infection by P. berghei ANKA. Liver metabolism was followed by NMR spectroscopy through the course of the disease in both male and female mice. Our results showed alterations in the level of several metabolites as a result of the infection. Metabolites like kynurenic acid, alanine, carnitine, and β-alanine showed significant alteration in the liver, suggesting altered kynurenic acid, glucose, fatty acid and amino acid pathways. Distinct sexual dimorphism was also observed in the global analysis of the liver metabolic profiles. Multiway principal component analysis (MPCA) was carried out on the liver, brain, and serum metabolic profile in order to explore the correlation of liver and brain metabolic profile to the metabolite profile of serum. Changes in such correlation profile also indicated distinct sexual dimorphism at the early stage of the disease. Indications are that the females are able to regulate their metabolism in the liver in such a way to maintain homeostasis in the blood. In males, however, choline in liver showed anticorrelation to choline content of serum indicating a higher phospholipid degradation process. The brain-serum correlation profile showed an altered energy metabolism in both the sexes. The differential organellar responses during disease progression have implications in malaria management.Entities:
Year: 2011 PMID: 21772982 PMCID: PMC3135115 DOI: 10.1155/2011/901854
Source DB: PubMed Journal: J Parasitol Res ISSN: 2090-0023
Figure 1OPLS-DA scores plot based on the 1H NMR metabolic profile of the liver. The experiments consisted of 12 male and 12 female mice. Eight male and 8 female mice were injected with P. berghei ANKA. On day 5, 4 infected males, 4 infected females, 2 control males, and 2 control females were sacrificed, and the liver is extracted with perchloric acid (early-stage of infection). Again on day 13 (late-stage infection). A/B, early- and late-stage infection males are compared with male controls; C/D, early- and late-stage infection females are compared with female controls. In each plot, the Q 2(cum) is shown at the bottom. The red triangle—profile of the infected animals and the black dots—the control animals.
Metabolites perturbed in the mouse liver during infection with P. berghei ANKA. Italicized metabolites could not be confirmed. Cystine, serine and phosphoserine could not be confirmed because their crosspeaks occur in very crowded regions of the spectrum. Presence of fatty acids cannot be confirmed due to low concentrations.
| Increased compound | Chemical | VIP | Loading | Decreased compound | Chemical shift | VIP value | Loading |
|---|---|---|---|---|---|---|---|
| Females early stage | |||||||
| N-methyl-a-aminobutyric acid, Ribonolactone | 3.82 | 3.01 | 0.242 | Beta-alanine | 3.18 | 5.66 | −0.455 |
| Dimethylglycine | 3.7 | 2.85 | 0.229 | O-phosphoethanolamine | 4.02 | 2.5 | −0.201 |
| Phosphocreatine, Creatine, Betaine | 3.9 | 2.72 | 0.219 | Unidentified | 3.66 | 2.12 | −0.171 |
| Unidentified | 3.46 | 2.58 | 0.207 | Sarcosine | 3.62 | 2.84 | −0.228 |
| Alanine, methylacetoacetic acid, acetylcholine | 3.74 | 1.91 | Choline, Creatinine | 4.06 | 2.37 | −0.191 | |
| Choline, | 3.5 | 1.5 | 0.153 | ||||
| 3-hydroxyisovaleric acid, 4-pyridoxic acid | 2.34 | 1.62 | 0.130 | ||||
|
| |||||||
| Female late stage | |||||||
| 2-hydroxy-2-methylbutyric acid | 0.94 | 3.01 | 0.242 | Dimethylglycine | 3.7 | 3.34 | −0.268 |
| 2-ethylacrylic acid | 0.98 | 2.41 | 0.194 | N-methyl-a-aminobutyric acid, ribonolactone | 3.82 | 3.34 | −0.268 |
| Diethyl-thiophosphate, O-phosphoethanolamine, Phosphoserine | 3.98 | 2.38 | 0.191 | Unconfirmed | 3.46 | 3.28 | −0.263 |
| Beta-alanine | 3.18 | 2.21 | 0.178 | N-methyl-a-aminobutyric acid,3-mercaptopyruvic acid | 3.86 | 3.05 | −0.245 |
| Dimethyl-sulphide, Acetyl-phosphate, Amino-acetone, cis-2-methylaconitate | 2.10 | 2.15 | 0.173 | Alanine, methylacetoacetic acid, acetylcholine | 3.74 | 2.73 | −0.219 |
| Putrescine, L-leucine, 2-hydroxy-2-methylbutyric acid | 1.7 | 2.03 | 0.163 | Lactate,long chain fatty acids | 1.3 | 2.18 | −0.175 |
| 3-hydroxyisovaleric acid, 4-pyridoxic acid | 2.34 | 1.87 | 0.150 | Glycine | 3.54 | 2.13 | −0.171 |
| 2-ethylacrylic acid, stearic acid | 1.02 | 1.82 | 0.146 | lactic acid, N-acetyl-L-alanine | 4.1 | 1.74 | −0.140 |
|
| |||||||
| Males late stage | |||||||
| Beta-alanine, Cystine | 3.18 | 3.26 | 0.262 | N-methyl-a-aminobutyric acid,Ribonolactone | 3.82 | 3.52 | −.282 |
| 2-hydroxy-2-methyl-butyric acid | 0.94 | 3.00 | 0.241 | N-methyl-a-aminobutyric acid,3-mercaptopyruvic acid | 3.86 | 3.38 | −.271 |
| 2-ethylacrylic acid | 0.98 | 2.44 | 0.196 | Serine, Dimethylglycine | 3.7 | 3.13 | −.251 |
| Dimethyl-sulphide, Acetyl-phosphate, Amino-acetone, cis-2-methylaconitate | 2.1 | 1.98 | 0.159 | Alanine, methylacetoacetic acid, acetylcholine | 3.74 | 2.99 | −.20 |
| Putrescine, 2-hydroxy-2-methylbutyric acid, L-leucine | 1.7 | 1.95 | 0.156 | Phosphocreatine, Creatine, Betaine | 3.9 | 2.44 | −.196 |
| 2-ethylacrylic acid, stearic acid | 1.02 | 1.77 | 0.142 | cis-aconitic acid | 3.46 | 2.33 | −.187 |
| Long-chain fatty acids | 0.9 | 1.73 | 0.139 | lactic acid, N-acetyl-L-alanine | 4.1 | 1.98 | −.160 |
| O-phosphoethanolamine, phosphoserine | 3.98 | 1.73 | 0.139 | Alanine, Acetylcholine, guanidinoacetic acid | 3.78 | 1.71 | −.136 |
Figure 2Perturbed metabolite levels in mouse liver at early- and late-stage malarial infection. All peak intensities have been calculated relative to the peak height of 0.132 mg/ml DSS present in every sample. Panels showing two metabolites represent overlapping 1H NMR resonances at the chemical shift mentioned. Where only chemical shifts are mentioned, identity of metabolites could not be confirmed. Black = males and grey = females. * indicates P < .05, + indicates P < .08 in comparison to the uninfected controls of the same sex.
Figure 3Perturbed metabolite levels in mouse liver at early- and late-stage malarial infection: comparison of effects in male and female animals. The average peak intensity for the metabolite in uninfected samples of the same sex was subtracted from individual peak intensities of infected animals at each stage of infection. The average change in intensity with respect to the same sex control is plotted here. * indicates P < .05, + indicates P < .08 in comparison to the males at each stage. Black = male, and grey = female. Panels showing two metabolites represent overlapping 1H NMR resonances at the chemical shift mentioned. Where only chemical shifts are mentioned, identity of metabolites could not be confirmed.
MPCA model statistics in terms of total explained variances by two PCs calculated in percentage.
| Model | Total variation explained (%) |
|---|---|
| Liver-serum correlation, female | |
| Control | 93.17 |
| Early infection | 98.15 |
| Late infection | 99.25 |
|
| |
| Liver- serum correlation, male | |
| Control | 96.40 |
| Early infection | 99.02 |
| Late infection | 98.08 |
|
| |
| Brain- serum correlation, female | |
| Control | 94.55 |
| Early infection | 98.81 |
| Late infection | 99.25 |
|
| |
| Brain- serum correlation, male | |
| Control | 96.72 |
| Early infection | 98.02 |
| Late infection | 98.58 |
Figure 4The liver and serum correlation profile depicted by MPCA PC2 loadings plot. The aliphatic region of the spectra is shown. (a–c) are females and (d–f) are the males. In each set, the left figure is the liver profile and the right one is the serum profile. The y-axis in each panel represents the loading axis. The compartmental loadings are obtained by cropping the model loading. (a/d): control, (b/e): early infection, and (c/f): late infection. Symbols: 1: branched chain amino acids, 2: choline, 3: glucose, 4: lactate, 5: lysine, 6: alanine, 7: trimethylamine oxide (TMAO), 8: glycine, 9: dimethylamine, and u: unidentified peak.
Figure 5The brain and serum correlation profile depicted by MPCA PC2 loadings plot. The aliphatic region of the spectra is shown. The panels (a–c) are the females and (d–f) are the males. In each set, the left figure is the brain profile and the right is the serum profile. The y-axis in each panel represents the loading axis. The compartmental loadings are obtained by cropping the model loading. (a/d): control, (b/e): early infection, and (c/f): late-infection. Symbols: 10: N-acetylaspartate, 11: sarcosine, 12: creatine, 13: betaine, u: unidentified peak.